Royal Bank of Canada »

Tevogen Bio Hldgs shares owned by Royal Bank of Canada

Quarter-by-quarter ownership of Tevogen Bio Hldgs (TVGN) shares owned by Royal Bank of Canada from 13F filings

Historical chart of Royal Bank of Canada investment in Tevogen Bio Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Tevogen Bio Hldgs held by Royal Bank of Canada consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tevogen Bio Hldgs by Royal Bank of Canada

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5k 5.8k 0.26
2024-06-30 $999 2.1k 0.49

More positions owned by Royal Bank of Canada

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Toronto Dominion Bk Ont Com New (TD)
Rbc Cad (RY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core S&p500 Etf (IVV)
Bk Nova Cad (BNS)
Ishares Tr Russell 2000 Etf (IWM)
Bank Of Montreal Cadcom (BMO)
JPMorgan Chase & Co. (JPM)
Enbridge (ENB)
Cibc Cad (CM)

View all positions for Royal Bank of Canada

Top funds holding Tevogen Bio Hldgs

Portland Global Advisors
Polar Securities
Cantor Fitzgerald, L. P.
Geode Capital Management
BlackRock
BlackRock
Vanguard Group
New York State Common Retirement Fund
Northern Trust
State Street Corporation
Charles Schwab Investment Management
Barclays
AQR Capital Management
Jpmorgan Chase & Co
Alpine Partners VI

View all funds holding Tevogen Bio Hldgs